109 reports of this reaction
1.6% of all PHENYTOIN SODIUM reports
#13 most reported adverse reaction
ATAXIA is the #13 most commonly reported adverse reaction for PHENYTOIN SODIUM, manufactured by Mylan Pharmaceuticals Inc.. There are 109 FDA adverse event reports linking PHENYTOIN SODIUM to ATAXIA. This represents approximately 1.6% of all 6,984 adverse event reports for this drug.
Patients taking PHENYTOIN SODIUM who experience ataxia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ATAXIA is a less commonly reported adverse event for PHENYTOIN SODIUM, but still significant enough to appear in the safety profile.
In addition to ataxia, the following adverse reactions have been reported for PHENYTOIN SODIUM:
The following drugs have also been linked to ataxia in FDA adverse event reports:
ATAXIA has been reported as an adverse event in 109 FDA reports for PHENYTOIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ATAXIA accounts for approximately 1.6% of all adverse event reports for PHENYTOIN SODIUM, making it a notable side effect.
If you experience ataxia while taking PHENYTOIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.